CL2013001978A1 - Compuestos biciclicos o oxabiciclicos nitrogenados, antagonistas no competitivos moduladores de receptores nicotinicos; composicion farmaceutica que los comprende; uso de los compuestos para el tratamiento o la prevencion de hipertension, adiccion a la nicotina, depresion o ansiedad, detrioros cognitivos, inflamacion. - Google Patents
Compuestos biciclicos o oxabiciclicos nitrogenados, antagonistas no competitivos moduladores de receptores nicotinicos; composicion farmaceutica que los comprende; uso de los compuestos para el tratamiento o la prevencion de hipertension, adiccion a la nicotina, depresion o ansiedad, detrioros cognitivos, inflamacion.Info
- Publication number
- CL2013001978A1 CL2013001978A1 CL2013001978A CL2013001978A CL2013001978A1 CL 2013001978 A1 CL2013001978 A1 CL 2013001978A1 CL 2013001978 A CL2013001978 A CL 2013001978A CL 2013001978 A CL2013001978 A CL 2013001978A CL 2013001978 A1 CL2013001978 A1 CL 2013001978A1
- Authority
- CL
- Chile
- Prior art keywords
- compounds
- oxabicyclic
- nitrogenated
- anxiety
- bicyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/38—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/40—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing six carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161430640P | 2011-01-07 | 2011-01-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2013001978A1 true CL2013001978A1 (es) | 2013-11-04 |
Family
ID=46457959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2013001978A CL2013001978A1 (es) | 2011-01-07 | 2013-07-05 | Compuestos biciclicos o oxabiciclicos nitrogenados, antagonistas no competitivos moduladores de receptores nicotinicos; composicion farmaceutica que los comprende; uso de los compuestos para el tratamiento o la prevencion de hipertension, adiccion a la nicotina, depresion o ansiedad, detrioros cognitivos, inflamacion. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20140288169A1 (es) |
| EP (1) | EP2661421A2 (es) |
| JP (1) | JP2014510026A (es) |
| KR (1) | KR20140038361A (es) |
| CN (1) | CN103402971A (es) |
| BR (1) | BR112013017405A2 (es) |
| CA (1) | CA2823848A1 (es) |
| CL (1) | CL2013001978A1 (es) |
| CO (1) | CO6821933A2 (es) |
| IL (2) | IL227319A0 (es) |
| MX (1) | MX2013007952A (es) |
| PE (1) | PE20140873A1 (es) |
| RU (1) | RU2013136851A (es) |
| SG (1) | SG191884A1 (es) |
| WO (1) | WO2012094437A2 (es) |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3514486A (en) * | 1968-05-23 | 1970-05-26 | Miles Lab | 3-isopropylnorbornanamine |
| US4883888A (en) * | 1984-07-13 | 1989-11-28 | The Procter & Gamble Company | Oxa-fenchyl amines useful for preparing high intensity sweeteners |
| DE69524223T2 (de) * | 1994-07-11 | 2002-08-22 | Allergan Sales Inc | Bicyclische derivate mit starrer konformation und adamantane als alpha-2-adrenergische blockierende agenzien |
| US5986142A (en) * | 1997-09-23 | 1999-11-16 | Poli Industria Chimica Spa | Process for preparing bicycloheptanamine compounds |
| WO2003018004A2 (en) * | 2001-08-29 | 2003-03-06 | Endo Pharmaceuticals, Inc. | Analgetic pyrroline derivatives |
| WO2005067909A1 (en) * | 2004-01-06 | 2005-07-28 | Yale University | Combination therapy with mecamylamine for the treatment of mood disorders |
| RU2006146985A (ru) * | 2004-05-28 | 2008-07-10 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Модуляторы мускариновых рецепторов |
| US7880007B2 (en) * | 2004-11-29 | 2011-02-01 | Vertex Pharmaceuticals Incorporated | Bicyclic substituted phenyl piperidine modulators of muscarinic receptors |
| EP1863490A2 (en) * | 2005-03-28 | 2007-12-12 | Vertex Pharmaceuticals Incorporated | Muscarinic modulators |
| US20090264650A1 (en) * | 2005-03-31 | 2009-10-22 | Nobuo Cho | Prophylactic/Therapeutic Agent for Diabetes |
| KR20080021082A (ko) * | 2005-06-20 | 2008-03-06 | 쉐링 코포레이션 | 히스타민 ｈ3 길항제로서 유용한 피페리딘 유도체 |
| JP2009507899A (ja) * | 2005-09-17 | 2009-02-26 | シュペーデル・エクスペリメンタ・アーゲー | 飽和ｏ−複素環により置換されたアルカン酸アミド |
| TW200730500A (en) * | 2005-12-20 | 2007-08-16 | Solvay Pharm Bv | 4, 5-dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators |
| AU2006328483A1 (en) * | 2005-12-20 | 2007-06-28 | Solvay Pharmaceuticals B.V. | 4,5-dihydro- (1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators |
| CL2008001503A1 (es) * | 2007-05-24 | 2008-07-04 | Wyeth Corp | Compuestos derivados de azaciclilbenzamidas, antagonistas de histamina-3; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para tratar un trastorno neurodegenerativo, como alzheimer, parkinso |
| WO2009146031A1 (en) * | 2008-03-31 | 2009-12-03 | University Of South Florida | Methods of treating disease-induced ataxia and non-ataxic imbalance |
| WO2010138842A1 (en) * | 2009-05-29 | 2010-12-02 | Xlterra, Inc. | Ketal esters of anhydropentitols and uses thereof |
| WO2013026852A2 (en) * | 2011-08-22 | 2013-02-28 | The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin | Derivatives of mecamylamine |
-
2012
- 2012-01-05 RU RU2013136851/04A patent/RU2013136851A/ru not_active Application Discontinuation
- 2012-01-05 BR BR112013017405A patent/BR112013017405A2/pt not_active IP Right Cessation
- 2012-01-05 CA CA2823848A patent/CA2823848A1/en not_active Abandoned
- 2012-01-05 SG SG2013052402A patent/SG191884A1/en unknown
- 2012-01-05 CN CN2012800094116A patent/CN103402971A/zh active Pending
- 2012-01-05 EP EP12731898.8A patent/EP2661421A2/en not_active Withdrawn
- 2012-01-05 MX MX2013007952A patent/MX2013007952A/es not_active Application Discontinuation
- 2012-01-05 US US13/978,583 patent/US20140288169A1/en not_active Abandoned
- 2012-01-05 WO PCT/US2012/020246 patent/WO2012094437A2/en active Application Filing
- 2012-01-05 KR KR1020137020674A patent/KR20140038361A/ko not_active Application Discontinuation
- 2012-01-05 JP JP2013548495A patent/JP2014510026A/ja active Pending
- 2012-01-05 PE PE2013001526A patent/PE20140873A1/es not_active Application Discontinuation
-
2013
- 2013-07-04 IL IL227319A patent/IL227319A0/en unknown
- 2013-07-05 CL CL2013001978A patent/CL2013001978A1/es unknown
- 2013-08-05 CO CO13186097A patent/CO6821933A2/es not_active Application Discontinuation
-
2014
- 2014-01-06 IL IL230334A patent/IL230334A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2661421A2 (en) | 2013-11-13 |
| WO2012094437A3 (en) | 2012-11-01 |
| WO2012094437A2 (en) | 2012-07-12 |
| IL230334A0 (en) | 2014-03-06 |
| CN103402971A (zh) | 2013-11-20 |
| SG191884A1 (en) | 2013-08-30 |
| CO6821933A2 (es) | 2013-12-31 |
| US20140288169A1 (en) | 2014-09-25 |
| CA2823848A1 (en) | 2012-07-12 |
| IL227319A0 (en) | 2013-09-30 |
| KR20140038361A (ko) | 2014-03-28 |
| BR112013017405A2 (pt) | 2016-10-04 |
| PE20140873A1 (es) | 2014-08-13 |
| JP2014510026A (ja) | 2014-04-24 |
| RU2013136851A (ru) | 2015-02-20 |
| MX2013007952A (es) | 2013-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2014003278A1 (es) | Compuestos derivados de tetrahidropirazolopirimidina, antagonistas o inhibidores de receptores similares a toll 7 y/u 8; mezcla racemica; composcion farmaceutica que los comprende; y metodo para el tratamiento de lupus eritematoso sistemico o lupus. | |
| CL2015001733A1 (es) | Compuestos derivados de lactamas fusionadas de arilo y heteroarilo, moduladores de ezh2; composicion farmaceutica que los comprende; uso del compuesto para el tratamiento del cancer. | |
| BR112014010179A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para a profilaxia ou tratamento de um estado ou condição | |
| CL2015000295A1 (es) | Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades. | |
| BR112014001279A2 (pt) | composto, uso do composto, composição farmacêutica, e, método para tratar um indivíduo que sofre com um distùrbio mediado pela tirosina cinase de bruton (btk) | |
| CL2014001103A1 (es) | Compuestos derivados de heteroaril piridona y aza-piridona sustituidas, inhibidores de btk quinasa; composicion farmaceutica que los comprende; proceso de preparacion de la composicion farmaceutica; kit farmaceutico; y uso para el tratamiento de trastornos inmunes, cancer, inflamacion, trastornos neurologicos, entre otros. | |
| GT201700023A (es) | Derivados de heterociclico opcionalmente condensados de piridimina útiles para el tratamiento de enfermedades inflamatorias, metabolicas, oncológicas y autoinmunitarias | |
| CL2014000543A1 (es) | Compuestos derivados de imidazopiridazinas sustituidas con amino, inhibidores de la quinasa ,mknk2; metodo de preparacion; compuestos intermediarios y su uso; composicion farmaceutica; combinacion farmaceutica; y su uso para el tratamiento del cancer. | |
| CL2013001964A1 (es) | Compuestos derivados de heterociclos, como inhibidores de bace 1 o 2; composicion farmaceutica que los comprende; combinacion farmaceutica; y su uso para el tratamiento o prevencion de la enfermedad de alzheimer o deterioro cognitivo leve, resistencia a la insulina, diabetes tipo 2, entre otras. | |
| CL2009000873A1 (es) | Compuestos derivados de ciclohepta[b]piridina, antagonistas del receptor de cgrp; composicion farmaceutica; y uso para el tratamiento de la migrana.b | |
| BRPI0912362A2 (pt) | antagonista do receptor nmda para o tratamento de transtornos neuropsiquiátricos | |
| CL2011000976A1 (es) | Compuestos derivados de isonicotinamida y carboxamida, antagonistas de los receptores de orexina; composicion farmaceutica que los comprende; y su uso para la prevencion de un trastorno del sueno. | |
| ECSP16078782A (es) | Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados | |
| CL2015001483A1 (es) | Compuestos derivados de hidroxiquinolina y otros heterociclos nitrogenados, antagonistas de los receptores muscarínicos y agonistas del receptor beta2 adrenérgico; composicion farmaceutica; combinacion farmaceutica; y su uso para el tratamiento o prevencion del asma, bronquitis cronica o epoc. | |
| CL2014000450A1 (es) | Compuestos derivados de n-(heteroarilmetil)-6-[(2-heteroarilciclopropil)metoxi]pririmidin-4-amina, inhibidores de pde10; composicion farmaceutica; y su uso para el tratamiento de un trastorno seleccionado de trastornos psicóticos, delirantes, entre otros. | |
| CL2014000849A1 (es) | Compuestos derivados de benzilindazoles sustituido, inhibidores de la quinasa bub1; procedimiento de fabricacion; composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento de enfermedades hiperproliferativas. | |
| CL2008002708A1 (es) | Compuestos derivados de azaciclilisoquinolinona e isoindolinona, antagonistas de histamina-3; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuestos; y uso del compuesto para el tratamiento de un trastorno cognitivo, | |
| ECSP16078779A (es) | Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados | |
| WO2014066799A3 (en) | Modulators of resistant androgen receptor | |
| MX2017005484A (es) | Compuestos antagonistas del receptor de dopamina d3. | |
| UY32734A (es) | Compuestos agonistas del receptor esfingosina 1-fosfato | |
| BR112014016736A8 (pt) | composto, composição farmacêutica, método para tratamento, uso de um composto e invenção | |
| CL2014001862A1 (es) | Compuestos derivados de morofolinilo sustituido, útiles como inhibidores de mogat-2; composicion farmaceutica que los comprende; uso en el tratamiento de hipertrigliceridemia. | |
| CR20160042A (es) | ANTAGONISTAS DE V1a PARA TRATAR TRASTORNOS DEL SUEÑO POR CAMBIO DE FASE | |
| ECSP13013016A (es) | Derivados de 2-amino-3-(imidazol-2-il)-piridin-4-ona, y su uso como inhibidores de la cinasa del receptor vegf |